Benign Prostatic
Hyperplasia (BPH)

With clear clinical advantages – Holmium laser enucleation of the prostate can be optimal choices for your patients.

• HoLEP laser provides excellent and durable clinical outcomes (PVR, Qmax, IPSS and QoL) with a reoperation* rate of only 0.7% at 10-year follow-up.¹
• The Lumenis Pulse 120H Laser System with MOSES Technology transforms BPH management, as it suits a majority of patients regardless of prostate size, anticoagulants therapy and age.^2-5
• HoLEP with MOSES Technology allows successful same-day discharge of >90% of patients thanks to faster enucleation and hemostasis time.^6,7

Compared with standard holmium, MOSES Technology can enable a tapered learning curve by providing better vision clarity and control during the procedure.⁷

*Reoperation as a result of recurrent obstruction from residual adenoma.